News Across Asia - Page 2

India Briefing

India's M&A Trends Q1 2026: Deals, Sectors, and Investment Outlook

05/04/2026

India’s Q1 2026 M&A (mergers and acquisitions) market saw a 5 percent volume surge to 710 deals despite falling values. Learn why mid-market shifts and outbound expansion are the new growth drivers in the country.

India Briefing

India Manufacturing Tracker 2026

05/04/2026

India Manufacturing Tracker 2026 brings you real-time updates on industry performance, manufacturing activity, PMI data, CAPEX spending, and policy support.

ASEAN Briefing

Beyond Capital Gains: Full Corporate Tax Exposure When Selling a Vietnam Subsidiary

05/04/2026

Selling a Vietnam subsidiary involves more than capital gains tax. Discover how tax structure, indirect transfers, and audit risks impact deal value.

China Briefing

Hong Kong Employment Compliance: What's New in 2026

05/04/2026

Hong Kong’s 2026 employment reforms reshape employer obligations through the new 468 rule, annual minimum wage adjustments, expanded statutory holidays, MPF offset removal, and tighter labor‑related regulation. Companies must prepare for broader compliance demands.

Middle East Briefing

Saudi Arabia's Real Estate Advertising Rules: Why It Matters for Investors and Market Entrants

05/04/2026

Saudi Arabia's new real estate advertising rules raise entry barriers and shift the market toward licensed, transparent, and institutionalized operations, increasing upfront costs but improving deal certainty. For investors, the reforms reduce due diligence and pre-investment risk while concentrating market access through compliant intermediaries and higher-quality, verified deal flow.

Vietnam Briefing

Vietnam’s Manufacturing Ecosystem and Global Supply Chain Positioning

05/04/2026

Amid a rapidly evolving global trade environment, Vietnam has emerged as a key manufacturing hub in Asia, positioning itself to move further up the global value chain and strengthen its role in regional and international supply networks.

ASEAN Briefing

Corporate Income Tax Filing in Singapore for Foreign Companies

05/01/2026

Learn when foreign companies must file corporate income tax in Singapore, key deadlines, tax rates, and how to avoid penalties and compliance risks.

India Briefing

Double Taxation Avoidance Agreements (DTAAs) and Your India Investment Strategy

05/01/2026

India has double taxation avoidance agreements (DTAAs) in place with over 90 countries, with certain tax treaties offering lower withholding tax (WHT) rates on certain types of income. This article examines how DTAAs can impact foreign firms and their India investment strategy.

India Briefing

BIS Certification in India (FMCS Scheme I): 2026 Guide for Foreign Manufacturers

05/01/2026

Learn how foreign manufacturers can obtain BIS certification under FMCS Scheme I, manage QCO compliance, avoid import disruptions, and streamline market entry into India.

China Briefing

China’s Nuclear Fusion Sector: What the 15th FYP Means for Businesses and Investors

05/01/2026

China’s nuclear fusion sector is rapidly taking shape as an emerging industrial market, with increasing investment and activity across reactor supply chains, advanced materials, and engineering systems. While commercial power generation remains a long-term goal for the 2030s–2040s, near-term business opportunities are already developing in component manufacturing, testing infrastructure, and technology partnerships.

Middle East Briefing

How to Choose the Right UAE Free Zone: Practical Guide for Foreign Investors

05/01/2026

Selecting the right UAE free zone enables cost-efficient, compliant, and flexible operations while providing foreign investors with a scalable gateway to expand across the Middle East, Africa, and Asia.

India Briefing

Why Indian Critical Drug Exports are Surging in 2026: The Role of FTAs

04/30/2026

India’s critical drug manufacturing enters a new growth phase in 2026. From oncology dominance to zero-duty access under new FTAs, learn how India is transitioning into a high-value global hub for specialty drugs, vaccines, & anti-infective formulations.